Latest Cash Management News

Audalia Resources plans a $450,000 share placement to advance its Medcalf project and bolster working capital, while continuing to explore further funding options for regulatory approvals.

Bell Financial Group surged to a $21.7 million half-year profit, more than doubling its net profit on stronger markets and the launch of its Bell Potter Private Wealth platform. The company also lifted its interim dividend by 67%, reflecting confidence in its diversified financial services model.

Elixinol Wellness (ASX: EXL) has posted a record quarterly revenue of A$4.3 million alongside a 45% gross margin, marking a clear shift from its US CBD origins to a diversified Australian wellness platform. Cost reductions and disciplined cash flow management underpin the company’s readiness to scale.

True North Copper (ASX:TNC) reported strong progress in Q4 FY2026, expanding its Mt Oxide copper system and consolidating its Cloncurry assets ahead of a key Pre-Feasibility Study.

Thor Energy reported a robust cash position of A$2.8 million at June 30, 2026, and confirmed natural hydrogen concentrations up to 3% at its HY-Range Project. The company awarded a fully funded 464 line-kilometre 2D seismic survey to Velseis, marking a key step towards drilling.

Artrya is advancing its commercial footprint in the US with two health systems now generating revenue and FDA clearance for its Salix Coronary Flow module expected in H2 2026.

Element 25 is on track to commission its Butcherbird manganese expansion in early 2027, while securing a substantial US Department of Energy grant to support its US battery materials facility.

Cooper Metals has completed its first RC drilling at Mt Isa East, visually spotting copper sulphides, and secured the Pyramid Gold Project through an asset swap, backed by a $979,500 placement.

MaxiPARTS upgrades FY26 operating profit guidance to $14.2 million, driven by strong cost control and a $9 million inventory reduction, while bolstering its executive team with key appointments.

Noxopharm reported significant progress in its Sofra technology, highlighting enhanced cancer drug potential and preparations for a US FDA clinical trial, while managing tight cash reserves.

Jcurve Solutions delivered a standout FY26 with a 178% jump in EBITDA and an 18% rise in annual recurring revenue, setting the stage for further growth in FY27.

Love Group Global Ltd (ASX:LVE) reported a record net operating cash flow of $974k for FY26, a 49% increase despite a 13% decline in customer cash receipts. The company plans to grow its matchmaking business in Asia and test expansion into the US and UK.